Ende Eric J 4
4 · NeuBase Therapeutics, Inc. · Filed Sep 12, 2022
Insider Transaction Report
Form 4
Ende Eric J
Director
Transactions
- Award
Stock option (right to buy)
2022-09-09+37,600→ 37,600 totalExercise: $0.60Exp: 2032-09-09→ Common Stock (37,600 underlying)
Footnotes (1)
- [F1]25% of the total shares shall vest on the first anniversary of September 9, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months.